Not medical advice. This site is general information only. In an emergency call your local emergency number. For advice about your own health, speak to a doctor, pharmacist or other qualified health professional.

Sitagliptin

DPP-4 Inhibitor2006
Drug ClassDPP-4 Inhibitor
Year Approved2006
Conditions TreatedType 2 diabetes
AvailabilityPrescription

About Sitagliptin

A DPP 4 inhibitor that enhances the bodys own incretin hormones. Sitagliptin or Januvia treats type 2 diabetes by prolonging the action of GLP 1, a hormone that stimulates insulin release after meals. It is well tolerated with minimal risk of hypoglycemia. Sitagliptin modestly lowers blood sugar. It is taken orally as a tablet. The drug is commonly combined with metformin. Its high price during patent protection has limited access in developing countries.

Related Medications